Acute Liver Injury and Bilateral Pulmonary Artery Thrombosis Due to Hypereosinophilic Syndrome  Internal Medicine. 2024;63(17):2415-2420
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38296476

Asciminib in Newly Diagnosed Chronic Myeloid Leukemia  New England Journal of Medicine. 2024;391(10):885-898
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38820078

Bone marrow necrosis and hyperinflammation after treatment with inotuzumab ozogamicin for B-cell acute lymphoblastic leukaemia  Lancet. 2024;404(10459):1253-1254
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39341644

Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis  Annals of Medicine. 2024;56(1):2338604
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38599340

CML 25 Years Later - Poised for Another Breakthrough?  New England Journal of Medicine. 2024;391(10):955-957
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39259899

Cognitive-behavioral stress management relieves anxiety, depression, and post-traumatic stress disorder in parents of pediatric acute myeloid leukemia patients: a randomized, controlled study  Hematology (Amsterdam, Netherlands). 2024;29(1):2293498
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38095309

Comprehensive analysis of the efficacy and safety of CAR T-cell therapy in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: a systematic review and meta-analysis  Annals of Medicine. 2024;56(1):2349796
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38738799

The Double-Edged Sword of Extremely High Prices for Gene Therapies in Sickle Cell Disease  JAMA. 2024;332(9):703-704
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39102257

Efficacy and safety of venetoclax-based combination therapy for previously untreated acute myeloid leukemia: a meta-analysis  Hematology (Amsterdam, Netherlands). 2024;29(1):2343604
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38703055

Gamma knife radiosurgery for orbital cavernous hemangioma: a systematic review and single-arm meta-analysis  Journal of Neuro-Oncology. 2024;169(2):221-231
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39075327

G-CSF + plerixafor versus G-CSF alone mobilized hematopoietic stem cells in patients with multiple myeloma and lymphoma: a systematic review and meta-analysis  Annals of Medicine. 2024;56(1):2329140
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38470973

Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B  New England Journal of Medicine. 2024;391(12):1108-1118
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39321362

Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial  Lancet Haematol. 2024;11(9):e646-e658
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39038479

Measurable Residual Disease and Clinical Outcomes in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis  JAMA Oncol. 2024;10(9):1221-1227
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38990562

Orofacial pain crisis is a frequently overlooked aspect of sickle cell anaemia  BMJ. 2024;386:q1898
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39231589

Paraneoplastic Eczematous Dermatitis With Palmoplantar Keratoderma as an Initial Manifestation of Acute Myeloid Leukemia  American Journal of Medicine. 2024;137(9):835-838
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38583753

Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia  New England Journal of Medicine. 2024;391(11):1015-1027
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39292928

Randomized controlled trial of twin-twin transfusion syndrome laser surgery: the sequential trial  American Journal of Obstetrics and Gynecology. 2024;231(3):365.e1-365.e15
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38897340

A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis  Annals of Hematology. 2024;103(9):3573-3583
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39145781

Rasburicase-induced hemolytic anemia and methemoglobinemia: a systematic review of current reports  Annals of Hematology. 2024;103(9):3399-3411
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37468669

Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial  American Journal of Hematology. 2024;99(9):1778-1789
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38884137

Safe re-immunization of mRNA-1273 COVID-19 vaccine after BNT162b2 mRNA COVID-19 vaccine-induced nonepisodic angioedema with eosinophilia  Postgraduate Medical Journal. 2024;100(1188):769-770
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38727579

Speckle tracking echocardiography and β-thalassemia major. A systematic review  Annals of Hematology. 2024;103(9):3335-3356
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37526674

A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy  Nature Medicine. 2024;30(9):2667-2678
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38977912

A systematic review of the management of eosinophilic dermatosis of hematological malignancy  International Journal of Dermatology. 2024;63(9):1164-1171
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38727148